All stock lists
GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
Healthcare · Diagnostics & Research
140.15+7.60 (+5.76%)
Insider Score
––Not scored
GRAL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
GRAL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 44.69 M | 40.78 M | 43.60 M | 36.19 M | 35.54 M |
| Revenue Growth (YoY) | 25.72 % | — | — | — | — |
| Cost of Revenue | 57.25 M | 55.09 M | 54.73 M | 49.93 M | 53.32 M |
| Gross Profit | -12.57 M | -14.31 M | -11.14 M | -13.73 M | -17.77 M |
| SG&A Expense | 88.36 M | 73.44 M | 66.38 M | 62.91 M | 66.45 M |
| R&D Expense | 47.43 M | 48.02 M | 46.90 M | 48.65 M | 46.63 M |
| Operating Expenses | 135.79 M | 121.46 M | 113.28 M | 111.56 M | 113.08 M |
| Operating Income | -148.36 M | -135.76 M | -124.41 M | -125.29 M | -130.85 M |
| Pretax Income | -166.71 M | -127.52 M | -116.52 M | -118.72 M | -152.86 M |
| Tax Provision | -56.46 M | -34.34 M | -17.34 M | -29.74 M | -38.87 M |
| Net Income | -110.25 M | -93.19 M | -99.18 M | -88.98 M | -113.98 M |
| EPS (Basic) | -2.56 | -2.29 | -2.44 | -2.46 | -3.18 |
| EPS (Diluted) | -2.56 | -2.29 | -2.44 | -2.46 | -3.18 |
| Shares Outstanding | 43.11 M | 40.64 M | 40.73 M | 36.12 M | 35.79 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.